Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma

Immunotherapy for the treatment of multiple myeloma

Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy

Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma

Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma

Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients

Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

Vaccination of multiple myeloma: Current strategies and future prospects

Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic